Go to home page icon Go to home page

Greg A. Johnson

A Senior Executive with over 30 years of progressive experience in Biotech and Clinical Research, with recognized expertise in strategic planning, project management and operations management, as well as in electronic data capture and the implementation and use of computerized systems in a clinical research setting.

An effective leader, communicator, and decision-maker with significant international experience.

Cagley Johnson Consulting Inc.
2011 — Present
Canada

Principal Consultant

Jun 2011 - Present
Victoria BC, Canada

Support pharma, biotech, and CRO clients with:

Current engagements include:

Kintara Therapeutics (https.kintara.com)

Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients who are failing or resistant to current treatment regimens.

Kintara's second-generation photodynamic therapy (PDT) photosensitizer agent (REM-001) has undergone late stage clinical development in previous clinical trials showing a complete response in approximately 80% of evaluable tumor sites. The lead indication for REM-001 Therapy is unresectable cutaneous metastatic breast cancer (CMBC).

CJC provides consulting services with Greg functioning as (Acting) Head of Operations for the company.

BioForum (https://bioforumgroup.com)

Bioforum is an innovative, data-oriented Clinical Research Organization (CRO) providing unique, high-quality, tailored solutions for efficient collection, standardization, and reporting of clinical data.

Greg provides consulting and business development support to the company.

MedaSystems (https://medasystems.com)

MedaSystems provides an easy to use, intuitive software solution for Expanded Access management that enables collaboration between life sciences teams and physicians. CJC provides related consultative expertise and services through a non-exclusive partnership with MedaSystems.

Previous engagements:

Rediscovery Life Sciences AKI LLC

CJC provided program management for the RLS-003 drug development program in Acute Kidney Injury from manufacturing through completion of a Phase 2 proof-of-concept study and the eventual transfer of the asset.

MedGenesis Therapeutix Inc.

CJC provided program management support, and website and IT support.

Greg servec on the MedGenesis Board of Directors from Apr 2019 to Aug 2024.

 

MedGenesis Therapeutix Inc.
2007 — 2017
Canada

Member Board of Directors

Apr 2019 - Aug 2024
Victoria BC, Canada

President and Chief Financial Officer

Oct 2012 - Mar 2017
Victoria BC, Canada

Responsibilities

Key Accomplishments

Chief Operating Officer
Senior Vice President, Operations Victoria BC

Mar 2007 - Sep 2012
Canada

Responsibilities

Key Accomplishments

PRA International

1992 - 2007
Germany, UK, USA, Canada

Vice President, Operations, Americas

Jan 2007 - Feb 2007
Reston VA, USA

Responsibilities

Vice President of Global Data Management

May 2006 - Dec 2006
Reston VA, USA

Jun 2004 - Apr 2006
Victoria BC, Canada

Responsibilities

Key Accomplishments

Vice President of Operations, Canada

Jul 2002 - May 2004
Victoria BC, Canada

Responsibilities

Key Accomplishments

Director of Product Management
Product Director, Data Management
Senior Systems Program Manager

Feb 1998 - Jun 2002
Charlottesville VA, USA

Responsibilities

Key Accomplishments

Manager, International Data Centre Dec 1996 - Jan 1998
Swansea, South Wales, UK

Responsibilities

Key Accomplishments

Supervisor Information Technology
Supervisor Clinical Data Services

Apr 1994 - Nov 1996
Mannheim, Germany

Supervisor Information Technology

Nov 1992 - Mar 1994
Mannheim, Germany

Qualifications

Publications

Posters

Presentations